Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ F-3 - Registration statement by foreign private issuers Filed: 2016-10-21 AccNo: 0001047469-16-016210 Size: 402 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-10-17 AccNo: 0001104659-16-150423 Size: 117 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-08-29 AccNo: 0001104659-16-141795 Size: 110 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-08-09 AccNo: 0001104659-16-138146 Size: 565 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-07-29 AccNo: 0001193125-16-663831 Size: 40 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-07-25 AccNo: 0001104659-16-134013 Size: 78 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 美东时间 2016-06-21 15:00 Nabriva Therapeutics AG at JMP Securities Life Sciences Conference 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 美东时间 2016-05-25 10:30 Nabriva Therapeutics AG at UBS Global Healthcare Conference 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-05-10 AccNo: 0000904454-16-001207 Size: 65 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-05-10 AccNo: 0001104659-16-119538 Size: 179 KB 网页链接